Enzon Pharmaceuticals Inc (ENZN.O)

ENZN.O on Consolidated Issue listed on NASDAQ Capital Market

29 Jan 2015
Change (% chg)

-- (--)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for ENZN.O


Enzon Pharmaceuticals, Inc. (Enzon) is a biotechnology company. The Company’s drug development programs utilize two platforms: Customized PEGylation Linker Technology (Customized Linker Technology) and third-generation messenger ribonucleic acid (mRNA) antagonists utilizing the Locked Nucleic Acid (LNA) technology. The Company... (more)
No analyst recommendations are available for ENZN.O.


Beta: 1.30
Market Cap(Mil.): $44.01
Shares Outstanding(Mil.): 44.14
Dividend: 0.10
Yield (%): --


  ENZN.O Industry Sector
P/E (TTM): 1.56 206.52 40.74
EPS (TTM): 0.64 -- --
ROI: 116.18 -0.84 18.19
ROE: 118.64 -2.65 19.08
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: ValuEngine, Inc.
Provider: New Constructs, LLC
Provider: MacroRisk Analytics/EconomicInvestor
Provider: S&P Capital IQ Quantitative Report
Provider: Pechala's Reports

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks